Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials.

Händel MN, Cardoso I, von Bülow C, Rohde JF, Ussing A, Nielsen SM, Christensen R, Body JJ, Brandi ML, Diez-Perez A, Hadji P, Javaid MK, Lems WF, Nogues X, Roux C, Minisola S, Kurth A, Thomas T, Prieto-Alhambra D, Ferrari SL, Langdahl B, Abrahamsen B

Open source

DOI: 10.1136/bmj-2021-068033
Published: 2023 May 2
Container: BMJ (Clinical research ed.)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmj-2021-068033,
  title = {Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials.},
  author = {Händel MN and Cardoso I and von Bülow C and Rohde JF and Ussing A and Nielsen SM and Christensen R and Body JJ and Brandi ML and Diez-Perez A and Hadji P and Javaid MK and Lems WF and Nogues X and Roux C and Minisola S and Kurth A and Thomas T and Prieto-Alhambra D and Ferrari SL and Langdahl B and Abrahamsen B},
  year = {2023},
  journal = {BMJ (Clinical research ed.)},
  doi = {10.1136/bmj-2021-068033},
  url = {https://doi.org/10.1136/bmj-2021-068033}
}

RIS

TY  - JOUR
TI  - Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials.
AU  - Händel MN
AU  - Cardoso I
AU  - von Bülow C
AU  - Rohde JF
AU  - Ussing A
AU  - Nielsen SM
AU  - Christensen R
AU  - Body JJ
AU  - Brandi ML
AU  - Diez-Perez A
AU  - Hadji P
AU  - Javaid MK
AU  - Lems WF
AU  - Nogues X
AU  - Roux C
AU  - Minisola S
AU  - Kurth A
AU  - Thomas T
AU  - Prieto-Alhambra D
AU  - Ferrari SL
AU  - Langdahl B
AU  - Abrahamsen B
PY  - 2023
JO  - BMJ (Clinical research ed.)
DO  - 10.1136/bmj-2021-068033
UR  - https://doi.org/10.1136/bmj-2021-068033
ER  -

APA

MN, H., I, C., C, V. B., JF, R., A, U., SM, N., R, C., JJ, B., ML, B., A, D., P, H., MK, J., WF, L., X, N., C, R., S, M., A, K., T, T., D, P., SL, F., B, L., & B, A. (2023). Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials.. BMJ (Clinical research ed.). https://doi.org/10.1136/bmj-2021-068033

Source records

pubmed · retrieved 2026-09-26T11:42:24.089Z
europe-pmc · retrieved 2026-09-26T11:42:24.092Z
hal · retrieved 2026-09-26T11:42:24.116Z